Hyolev MB URINARY ANTISEPTIC Tablets, Each tablet for oral administration contains: Hyoscyamine S...

FDA Drug Recall #D-0155-2017 — Class II — October 24, 2016

Recall Summary

Recall Number D-0155-2017
Classification Class II — Moderate risk
Date Initiated October 24, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Burel Pharmaceuticals Inc
Location Richland, MS
Product Type Drugs
Quantity 2861 bottles

Product Description

Hyolev MB URINARY ANTISEPTIC Tablets, Each tablet for oral administration contains: Hyoscyamine Sulfate 0.12 mg, Methenamine 81 mg, Methylene Blue 10.8 mg, Phenyl Salicylate 32.4 mg, Sodium Phosphate Monobasic 40.8 mg, 90 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-301-90

Reason for Recall

CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures

Distribution Pattern

Nationwide

Lot / Code Information

LOT # 29001501, EXP 07/17

Other Recalls from Burel Pharmaceuticals Inc

Recall # Classification Product Date
D-0162-2017 Class II Phenazopyridine Hydrochloride Tablets, USP, 200... Oct 24, 2016
D-0159-2017 Class II AZUPHEN MB URINARY ANTISEPTIC Capsules, Each ca... Oct 24, 2016
D-0161-2017 Class II Phenazopyridine Hydrochloride Tablets, USP, 100... Oct 24, 2016
D-0157-2017 Class II URAMIT MB URINARY ANTISEPTIC Capsules, Each cap... Oct 24, 2016
D-0160-2017 Class II Indiomin MB URINARY ANTISEPTIC, ANTISPASMODIC C... Oct 24, 2016

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.